Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Fibromyalgia Treatment Market, by Drug Class
1.4.2 Europe Fibromyalgia Treatment Market, by Distribution Channel
1.4.3 Europe Fibromyalgia Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Fibromyalgia Treatment Market by Drug Class
3.1 Europe Anticonvulsants Market by Country
3.2 Europe Antidepressants Market by Country
3.3 Europe Muscle Relaxants Market by Country
3.4 Europe Others Market by Country
Chapter 4. Europe Fibromyalgia Treatment Market by Distribution Channel
4.1 Europe Drug stores & Retail Pharmacies Market by Country
4.2 Europe Hospital Pharmacies Market by Country
4.3 Europe Online Providers Market by Country
Chapter 5. Europe Fibromyalgia Treatment Market by Country
5.1 Germany Fibromyalgia Treatment Market
5.1.1 Germany Fibromyalgia Treatment Market by Drug Class
5.1.2 Germany Fibromyalgia Treatment Market by Distribution Channel
5.2 UK Fibromyalgia Treatment Market
5.2.1 UK Fibromyalgia Treatment Market by Drug Class
5.2.2 UK Fibromyalgia Treatment Market by Distribution Channel
5.3 France Fibromyalgia Treatment Market
5.3.1 France Fibromyalgia Treatment Market by Drug Class
5.3.2 France Fibromyalgia Treatment Market by Distribution Channel
5.4 Russia Fibromyalgia Treatment Market
5.4.1 Russia Fibromyalgia Treatment Market by Drug Class
5.4.2 Russia Fibromyalgia Treatment Market by Distribution Channel
5.5 Spain Fibromyalgia Treatment Market
5.5.1 Spain Fibromyalgia Treatment Market by Drug Class
5.5.2 Spain Fibromyalgia Treatment Market by Distribution Channel
5.6 Italy Fibromyalgia Treatment Market
5.6.1 Italy Fibromyalgia Treatment Market by Drug Class
5.6.2 Italy Fibromyalgia Treatment Market by Distribution Channel
5.7 Rest of Europe Fibromyalgia Treatment Market
5.7.1 Rest of Europe Fibromyalgia Treatment Market by Drug Class
5.7.2 Rest of Europe Fibromyalgia Treatment Market by Distribution Channel
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 AbbVie, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Novartis AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Eli Lilly And Company
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 Amneal Pharmaceuticals, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.5.4 Research & Development Expenses
6.6 Teva Pharmaceutical Industries Ltd.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.7 Zydus Lifesciences Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.8 Lupin Limited
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Recent strategies and developments:
6.8.3.1 Trials and Approvals:
6.9 Viatris, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
6.10. Sun Pharmaceutical Industries Ltd.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expenses



List of Figures

FIG 1 Methodology for the research
FIG 2 Europe Fibromyalgia Treatment Market share by Drug Class, 2022
FIG 3 Europe Fibromyalgia Treatment Market share by Drug Class, 2030
FIG 4 Europe Fibromyalgia Treatment Market by Drug Class, 2019 - 2030, USD Million
FIG 5 Europe Fibromyalgia Treatment Market share by Distribution Channel, 2022
FIG 6 Europe Fibromyalgia Treatment Market share by Distribution Channel, 2030
FIG 7 Europe Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 Europe Fibromyalgia Treatment Market share by Country, 2022
FIG 9 Europe Fibromyalgia Treatment Market share by Country, 2030
FIG 10 Europe Fibromyalgia Treatment Market by Country, 2019 - 2030, USD Million
FIG 11 Swot analysis: Abbott laboratories

List of Tables

TABLE 1 Europe Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 2 Europe Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 3 Europe Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 Europe Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 5 Europe Anticonvulsants Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Anticonvulsants Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Antidepressants Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Antidepressants Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Muscle Relaxants Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Muscle Relaxants Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 14 Europe Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 15 Europe Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
TABLE 23 Germany Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 24 Germany Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 25 Germany Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 26 Germany Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 27 Germany Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 28 Germany Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 29 UK Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 30 UK Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 31 UK Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 32 UK Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 33 UK Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 UK Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 France Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 36 France Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 37 France Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 France Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 39 France Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 France Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 Russia Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 42 Russia Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 43 Russia Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 44 Russia Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 45 Russia Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Russia Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 Spain Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 48 Spain Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 49 Spain Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 50 Spain Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 51 Spain Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 Spain Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 53 Italy Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 54 Italy Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 55 Italy Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 56 Italy Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 57 Italy Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Italy Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 Rest of Europe Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 60 Rest of Europe Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 61 Rest of Europe Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 62 Rest of Europe Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 63 Rest of Europe Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 Rest of Europe Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 65 Key Information – Abbott Laboratories
TABLE 66 Key information – AbbVie, Inc.
TABLE 67 Key Information – Novartis AG
TABLE 68 Key Information – Eli Lilly And Company
TABLE 69 Key Information – Amneal Pharmaceuticals, INc.
TABLE 70 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 71 Key Information – Zydus Lifesciences Ltd.
TABLE 72 Key Information – Lupin Limited
TABLE 73 key information – Viatris, Inc.
TABLE 74 Key Information – Sun Pharmaceutical Industries Ltd.